Browse by Journal Title

2012

New therapeutic pathways in the RAS.
Bader, M. and Santos, R.A. and Unger, T. and Steckelings, U.M.
Journal of the Renin Angiotensin Aldosterone System 13 (4): 505-508. December 2012

2011

Vitamin D review.
Mueller, D.N. and Kleinewietfeld, M. and Kvakan, H.
Journal of the Renin Angiotensin Aldosterone System 12 (2): 125-128. June 2011

2010

The past, present and future of angiotensin II type 2 receptor stimulation.
Steckelings, U.M. and Rompe, F. and Kaschina, E. and Namsolleck, P. and Grzesiak, A. and Funke-Kaiser, H. and Bader, M. and Unger, T.
Journal of the Renin Angiotensin Aldosterone System 11 (1): 67-73. March 2010

2008

Renin-angiotensin system-related highlights from the High Blood Pressure Research Conference annual meeting.
Luft, F.C.
Journal of the Renin Angiotensin Aldosterone System 9 (4): 242-247. December 2008

Effects of the direct renin inhibitor aliskiren and atenolol alone or in combination in patients with hypertension.
Dietz, R. and Dechend, R. and Yu, C.M. and Bheda, M. and Ford, J. and Prescott, M.F. and Keefe, D.L.
Journal of the Renin Angiotensin Aldosterone System 9 (3): 163-175. September 2008

The Bothrops legacy: Vasoactive peptides from Brazil.
Luft, F.C.
Journal of the Renin Angiotensin Aldosterone System 9 (1): 57-64. 1 March 2008

2007

The second life of the (pro)renin receptor.
Bader, M.
Journal of the Renin Angiotensin Aldosterone System 8 (4): 205-208. December 2007

Spotlight on renin. Mechanisms of hypertension-induced target organ damage.
Mueller, D.N.
Journal of the Renin Angiotensin Aldosterone System 8 (3): 148-150. September 2007

Low-dose renin inhibitor and low-dose AT(1)-receptor blocker therapy ameliorate target-organ damage in rats harbouring human renin and angiotensinogen genes.
Dechend, R. and Shagdarsuren, E. and Gratze, P. and Fiebeler, A. and Pilz, B. and Meiners, S. and Derer, W. and Feldman, D.L. and Webb, R. and Mueller, D.N.
Journal of the Renin Angiotensin Aldosterone System 8 (2): 81-84. June 2007

2006

Achieving the goal of optimised renin system suppression: preclinical experience with a direct renin inhibitor.
Luft, F.C.
Journal of the Renin Angiotensin Aldosterone System 7 (Suppl 2): S12-S15. December 2006

2003

Telmisartan effectiveness on left ventricular MAss reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension - a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months - rationale and study design.
Friedrich, M.G. and Dahlof, B. and Sechtem, U. and Unger, T. and Knecht, M. and Dietz, R.
Journal of the Renin Angiotensin Aldosterone System 4 : 234-243. 1 January 2003

2000

Neurohumoral blockade in CHF management.
Willenbrock, R. and Philipp, S. and Mitrovic, V. and Dietz, R.
Journal of the Renin Angiotensin Aldosterone System 1 (Suppl 1): 24-30. September 2000